InflaRx (IFRX) Assets Average (2017 - 2026)

InflaRx's (IFRX) quarterly Assets Average came in at $60.8 million in Q1 2026, down 29.66% year-on-year from $86.4 million in Q1 2025, and down 13.48% quarter-over-quarter from $70.2 million in Q4 2025.

InflaRx (IFRX) Assets Average (2017 - 2026) Analysis & Trends

InflaRx has disclosed Assets Average across 10 years of filings, most recently posting $60.8 million for Q1 2026.

  • Assets Average for Q1 2026 came in at $60.8 million, down 29.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $60.8 million (down 29.66% YoY), and the FY2025 annual result was $72.8 million, down 30.9% from the prior year.
  • Assets Average came in at $60.8 million for Q1 2026 at InflaRx, down from $70.2 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $142.9 million in Q3 2023 to a low of $60.8 million in Q1 2026.
  • The 5-year median for Assets Average is $108.3 million (2022), against an average of $104.5 million.
  • Across the five-year window, Assets Average gained 24.84% in 2023 and sank 37.57% in 2024, its largest moves.
  • InflaRx's Assets Average stood at $108.3 million in 2022, then climbed by 24.84% to $135.1 million in 2023, then slumped by 37.57% to $84.4 million in 2024, then dropped by 16.77% to $70.2 million in 2025, then declined by 13.48% to $60.8 million in 2026.
  • The last three Assets Average figures came in at $60.8 million (Q1 2026), $70.2 million (Q4 2025), and $79.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 33.42 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 795.91 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 13.04 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 1.72 Bn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 40.89 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 26.03 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 10.06 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 26.06 Bn
9 Abivax 94.26 Bn 94.26 Bn - 660.38 Mn
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40 60.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 60.76 Mn
Dec 31, 2025 70.22 Mn
Sep 30, 2025 79.65 Mn
Jun 30, 2025 87.32 Mn
Mar 31, 2025 86.37 Mn
Dec 31, 2024 84.37 Mn
Sep 30, 2024 93.85 Mn
Jun 30, 2024 108.27 Mn
Mar 31, 2024 122.84 Mn
Dec 31, 2023 135.15 Mn
Sep 30, 2023 142.87 Mn
Jun 30, 2023 118.71 Mn
Mar 31, 2023 98.56 Mn
Dec 31, 2022 108.26 Mn
Sep 30, 2022 117.18 Mn
Jun 30, 2022 125.74 Mn
Mar 31, 2022 136.16 Mn
Dec 31, 2021 147.86 Mn
Sep 30, 2021 157.59 Mn
Jun 30, 2021 170.11 Mn